Ramucirumab is a monoclonal antibody used to treat advanced cancers by inhibiting VEGFR-2, preventing tumor growth. It’s approved for gastric, lung, colorectal, and liver cancers, often combined with chemotherapy for effectiveness. Get More Insights: https://wemarketresearch.com/reports/ramucirumab-market/1550